{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:06:47Z","timestamp":1785434807568,"version":"3.56.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.yexcr.2023.113563","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T20:07:00Z","timestamp":1679342820000},"page":"113563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma"],"prefix":"10.1016","volume":"426","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenbin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7591-9423","authenticated-orcid":false,"given":"Ying","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2023.113563_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2023.113563_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.635731","article-title":"The progress in the treatment of hepatocellular carcinoma with portal vein tumor thrombus","volume":"11","author":"Luo","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000503685","article-title":"Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus (2018 edition)","volume":"9","author":"Cheng","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.yexcr.2023.113563_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.radonc.2019.05.006","article-title":"Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: an open-label randomized controlled trial","volume":"140","author":"Sun","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0038-1666805","article-title":"Hepatocellular carcinoma with portal vein tumor involvement: best management strategies","volume":"38","author":"Liu","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.yexcr.2023.113563_bib6","article-title":"Efficacy and safety of apatinib in advanced hepatocellular carcinoma: a multicenter real world retrospective study","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2023.113563_bib7","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1245\/s10434-019-07223-z","article-title":"Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with hepatic vein invasion: a propensity score matching analysis","volume":"26","author":"Zhang","year":"2019","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.803133","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy in hepatocellular carcinoma: where do we stand?","volume":"11","author":"Rizzo","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/jcp.27324","article-title":"Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexcr.2023.113563_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01225689","article-title":"Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy","volume":"121","author":"Li","year":"1995","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2011.08.008","article-title":"MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma","volume":"56","author":"Liu","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2023.113563_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ccr.2012.07.023","article-title":"TGF-\u03b2-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma","volume":"22","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2023.113563_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.cancergen.2015.06.002","article-title":"Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma","volume":"208","author":"Zhang","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.yexcr.2023.113563_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nm843","article-title":"Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning","volume":"9","author":"Ye","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2023.113563_bib15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.25512","article-title":"Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis","volume":"55","author":"Wong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2023.113563_bib16","article-title":"Recurrently deregulated lncRNAs in hepatocellular carcinoma","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2023.113563_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.20892\/j.issn.2095-3941.2018.0184","article-title":"Identification of portal vein tumor thrombus with an independent clonal origin in hepatocellular carcinoma via multi-omics data analysis","volume":"16","author":"Liu","year":"2019","journal-title":"Cancer Biol. Med"},{"key":"10.1016\/j.yexcr.2023.113563_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12920-019-0586-4","article-title":"Integrative molecular analysis of metastatic hepatocellular carcinoma","volume":"12","author":"Wang","year":"2019","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.yexcr.2023.113563_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0039-1685539","article-title":"Contributions of fibroblasts, extracellular matrix, stiffness, and mechanosensing to hepatocarcinogenesis","volume":"39","author":"Filliol","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.yexcr.2023.113563_bib20","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.21037\/jgo-21-433","article-title":"Screening potential prognostic biomarkers for portal vein emboli in patients with hepatocellular carcinoma","volume":"12","author":"Zhou","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.21037\/jgo-21-162","article-title":"Transcriptome sequencing-based personalized analysis of hepatocellular carcinoma patients with portal vein tumor thrombus","volume":"12","author":"Qiu","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12935-021-02108-2","article-title":"Identification and integrative analysis of ACLY and related gene panels associated with immune microenvironment reveal prognostic significance in hepatocellular carcinoma","volume":"21","author":"Xu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexcr.2023.113563_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.678670","article-title":"Cancer-associated fibroblasts promote vascular invasion of hepatocellular carcinoma via downregulating decorin-integrin \u03b21 signaling","volume":"9","author":"Zheng","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2023.113563_bib24","doi-asserted-by":"crossref","first-page":"64957","DOI":"10.18632\/oncotarget.11778","article-title":"Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma","volume":"7","author":"Hou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2023.113563_bib25","doi-asserted-by":"crossref","first-page":"11786","DOI":"10.18632\/aging.202876","article-title":"Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma","volume":"13","author":"Lin","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.yexcr.2023.113563_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature21356","article-title":"Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity","volume":"543","author":"Turner","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2023.113563_bib27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2023.113563_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2023.113563_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007362","article-title":"Cancer epigenetics: moving forward","volume":"14","author":"Nebbioso","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.yexcr.2023.113563_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2023.113563_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13059-018-1492-3","article-title":"Homeobox oncogene activation by pan-cancer DNA hypermethylation","volume":"19","author":"Su","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.yexcr.2023.113563_bib32","doi-asserted-by":"crossref","first-page":"23849","DOI":"10.18632\/aging.104047","article-title":"Integrative analysis reveals novel driver genes and molecular subclasses of hepatocellular carcinoma","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.yexcr.2023.113563_bib33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41467-017-00991-w","article-title":"Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer","volume":"8","author":"Woo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2023.113563_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.30146","article-title":"Global DNA 5-hydroxymethylcytosine and 5-formylcytosine contents are decreased in the early stage of hepatocellular carcinoma","volume":"69","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2023.113563_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ijc.31667","article-title":"DNA methylation accumulation in gastric mucosa adjacent to cancer after Helicobacter pylori eradication","volume":"144","author":"Tahara","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2023.113563_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41366-018-0065-6","article-title":"Identification of an episignature of human colorectal cancer associated with obesity by genome-wide DNA methylation analysis","volume":"43","author":"Crujeiras","year":"2019","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.yexcr.2023.113563_bib37","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/ijc.31765","article-title":"Genome-wide DNA methylation profiling of primary colorectal laterally spreading tumors identifies disease-specific epimutations on common pathways","volume":"143","author":"Zhu","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2023.113563_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082332","article-title":"Hypermethylation of SCAND3 and Myo1g gene are potential diagnostic biomarkers for hepatocellular carcinoma","volume":"12","author":"Xu","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2023.113563_bib39","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1073\/pnas.1418962112","article-title":"Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display","volume":"112","author":"Nair","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2023.113563_bib40","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.neo.2020.09.007","article-title":"Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients","volume":"22","author":"Fan","year":"2020","journal-title":"Neoplasia"},{"key":"10.1016\/j.yexcr.2023.113563_bib41","doi-asserted-by":"crossref","first-page":"24132","DOI":"10.18632\/oncotarget.4432","article-title":"Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma","volume":"6","author":"Liao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2023.113563_bib42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jhep.2008.10.019","article-title":"Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A","volume":"50","author":"Zheng","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2023.113563_bib43","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/655398","article-title":"DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection","volume":"202","author":"Kaur","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.yexcr.2023.113563_bib44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-018-0843-8","article-title":"Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a","volume":"17","author":"Xin","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2023.113563_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1535370220963197","article-title":"Lnc-ATG9B-4 aggravates progress of hepatocellular carcinoma through cell proliferation and migration by upregulating CDK5","volume":"246","author":"Li","year":"2021","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.yexcr.2023.113563_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13046-020-01576-0","article-title":"Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1","volume":"39","author":"Song","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2023.113563_bib48","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3892\/mmr.2015.4716","article-title":"Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin","volume":"13","author":"Chang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yexcr.2023.113563_bib49","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2023.113563_bib50","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.ejso.2013.11.008","article-title":"MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma","volume":"40","author":"Wang","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40620-016-0311-8","article-title":"Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs)","volume":"30","author":"Cosmai","year":"2017","journal-title":"J. Nephrol."},{"key":"10.1016\/j.yexcr.2023.113563_bib52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/1078-0432.CCR-14-3358","article-title":"Soluble vascular endothelial growth factor (sVEGF) and the risk of venous thromboembolism in patients with cancer: results from the vienna cancer and thrombosis study (CATS)","volume":"22","author":"Posch","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib53","first-page":"649","article-title":"Cancer-associated thrombotic microangiopathy","volume":"10","author":"Govind Babu","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.yexcr.2023.113563_bib54","first-page":"5450","article-title":"Expression and role of VEGFA and miR-381 in portal vein tumor thrombi in patients with hepatocellular carcinoma","volume":"15","author":"Wang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.yexcr.2023.113563_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/BD-190409","article-title":"Role of CD44 in breast cancer","volume":"39","author":"Al-Othman","year":"2020","journal-title":"Breast Dis."},{"key":"10.1016\/j.yexcr.2023.113563_bib56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12072-020-10130-1","article-title":"S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma","volume":"15","author":"Qi","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.yexcr.2023.113563_bib57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2017.02.011","article-title":"Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis","volume":"394","author":"Chen","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2023.113563_bib58","first-page":"4418","article-title":"Hepatitis B virus-X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma","volume":"16","author":"Wu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2023.113563_bib59","article-title":"The association of HMGB1 gene with the prognosis of HCC","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2023.113563_bib60","doi-asserted-by":"crossref","first-page":"22527","DOI":"10.3390\/ijms160922527","article-title":"The role of HMGB1 signaling pathway in the development and progression of hepatocellular carcinoma: a review","volume":"16","author":"Wang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2023.113563_bib61","first-page":"479","article-title":"Elevated HMGB1 expression induced by hepatitis B virus X protein promotes epithelial-mesenchymal transition and angiogenesis through STAT3\/miR-34a\/NF-\u03baB in primary liver cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib62","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ncb3525","article-title":"Actin cortex architecture regulates cell surface tension","volume":"19","author":"Chugh","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexcr.2023.113563_bib63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1091\/mbc.e04-07-0555","article-title":"Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells","volume":"16","author":"Hotulainen","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yexcr.2023.113563_bib64","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1002\/ctm2.366","article-title":"Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1\/AKT pathway","volume":"11","author":"Yao","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.yexcr.2023.113563_bib65","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s11427-016-9042-y","article-title":"MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition","volume":"60","author":"Lv","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.yexcr.2023.113563_bib66","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/onc.2014.84","article-title":"RMP promotes venous metastases of hepatocellular carcinoma through promoting IL-6 transcription","volume":"34","author":"Zhang","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2023.113563_bib67","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2147\/CMAR.S158547","article-title":"Expression of 4E-BP1 and phospho-4E-BP1 correlates with the prognosis of patients with clear cell renal carcinoma","volume":"10","author":"Li","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib68","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s12032-014-0940-5","article-title":"Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinoma","volume":"31","author":"Fang","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2559.2012.04236.x","article-title":"Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas","volume":"61","author":"Korkolopoulou","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.yexcr.2023.113563_bib70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/CMAR.S230849","article-title":"4E-BP1(Thr46) phosphorylation association with poor prognosis in quantitative phosphoproteomics of portal vein tumor thrombus revealed that 4E-BP1Thr46 phosphorylation is associated with poor prognosis in HCC","volume":"12","author":"Lin","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib71","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1021\/pr100412w","article-title":"Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients","volume":"9","author":"Guo","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib72","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2023.113563_bib73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2010.10.007","article-title":"The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets","volume":"21","author":"Yang","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2023.113563_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020405","article-title":"Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy","volume":"18","author":"Tahmasebi Birgani","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2023.113563_bib75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.21037\/jgo.2017.06.09","article-title":"How does the tumor microenvironment play a role in hepatobiliary tumors?","volume":"9","author":"Kamil","year":"2018","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.650963","article-title":"AXL overexpression in tumor-derived endothelial cells promotes vessel metastasis in patients with hepatocellular carcinoma","volume":"11","author":"Chai","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2023.113563_bib77","first-page":"2187","article-title":"Irradiated endothelial cells modulate the malignancy of liver cancer cells","volume":"17","author":"Kim","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2023.113563_bib78","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13027-019-0229-6","article-title":"PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma","volume":"14","author":"Li","year":"2019","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.yexcr.2023.113563_bib79","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1158\/0008-5472.CAN-03-2958","article-title":"Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor","volume":"66","author":"Lanzen","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib80","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1158\/1078-0432.CCR-06-1967","article-title":"Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis","volume":"13","author":"Rofstad","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib81","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/hep.27320","article-title":"Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma","volume":"60","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2023.113563_bib82","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1084\/jem.20181827","article-title":"Context-dependent EMT programs in cancer metastasis","volume":"216","author":"Aiello","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2023.113563_bib83","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/0008-5472.CAN-15-0977","article-title":"Hypoxia-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis","volume":"76","author":"Ye","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yexcr.2018.03.025","article-title":"Hypoxia-induced HMGB1 expression of HCC promotes tumor invasiveness and metastasis via regulating macrophage-derived IL-6","volume":"367","author":"Jiang","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2023.113563_bib86","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1615\/CritRevImmunol.v30.i5.30","article-title":"Regulatory T-cell trafficking: from thymic development to tumor-induced immune suppression","volume":"30","author":"Mailloux","year":"2010","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2023.113563_bib87","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1503\/cjs.028009","article-title":"Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma","volume":"54","author":"Shen","year":"2011","journal-title":"Can. J. Surg."},{"key":"10.1016\/j.yexcr.2023.113563_bib88","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1756-9966-29-156","article-title":"Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombus","volume":"29","author":"Li","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib89","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00062752-200303000-00007","article-title":"Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases","volume":"10","author":"Heissig","year":"2003","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.yexcr.2023.113563_bib90","first-page":"588","article-title":"Experimental study on enhancement of the metastatic potential of portal vein tumor thrombus-originated hepatocellular carcinoma cells using portal vein serum","volume":"26","author":"Tang","year":"2014","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib91","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.7150\/jca.38209","article-title":"Macrovascular endothelial cells enhance the motility of liver cancer cells by up-regulation of MMP-3, activation of integrin\/FAK signaling pathway and induction of non-classical epithelial-mesenchymal transition","volume":"11","author":"Ding","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.yexcr.2023.113563_bib92","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/or.2013.2872","article-title":"Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling","volume":"31","author":"Han","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2023.113563_bib93","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2023.113563_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2008.11.006","article-title":"Hexokinase-2 bound to mitochondria: cancer's stygian link to the \"Warburg Effect\" and a pivotal target for effective therapy","volume":"19","author":"Mathupala","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2023.113563_bib95","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","article-title":"The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression","volume":"95","author":"Vaupel","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.yexcr.2023.113563_bib96","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113563_bib97","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.semcancer.2005.04.009","article-title":"Pyruvate kinase type M2 and its role in tumor growth and spreading","volume":"15","author":"Mazurek","year":"2005","journal-title":"Semin. Cancer Biol."},{"issue":"Suppl 1","key":"10.1016\/j.yexcr.2023.113563_bib98","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1079\/BJN2001454","article-title":"Pyruvate kinase type M2: a crossroad in the tumor metabolome","volume":"87","author":"Mazurek","year":"2002","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.yexcr.2023.113563_bib99","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2023.113563_bib100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-017-0748-y","article-title":"HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma","volume":"16","author":"Xu","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2023.113563_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2012.04.144","article-title":"ATP-citrate lyase: a mini-review","volume":"422","author":"Chypre","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2023.113563_bib102","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejca.2022.09.031","article-title":"Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis","volume":"177","author":"Viscardi","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexcr.2023.113563_bib103","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/17474124.2022.2064273","article-title":"Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?","volume":"16","author":"Rizzo","year":"2022","journal-title":"Expet Rev. Gastroenterol. Hepatol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482723001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482723001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:22:18Z","timestamp":1762147338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482723001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0014482723001106"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2023.113563","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2023.113563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113563"}}